Skip to main content

Table 3 Co-enrollment decision-making grid

From: Methods in the design and implementation of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial

 

Impact of co-enrollment

Trial A

Trial B

Scientific integrity

 Intervention-related

  1. Population of concern

Overlap?

  

  2. Enrollment window

Which closes first?

  

  3. Timing of intervention

Overlap?

  

  4. Study period

Overlap?

  

  5. Exclusion criteria

Conflict?

  

 Overlapping endpoints

  6. Primary endpoint

Overlap?

  

Potential impact?

  7. Secondary and exploratory endpoints

Overlap?

  

Potential impact?

 Other

  8. Magnitude of interaction

Known/unknown?

  

Dilution/enhancement of effect?

  9. Level of randomization

Same/different?

  

  10. Timing of randomization

Same/different?

  

  11. Potential of imbalance

Yes/no?

  

  12. Effect of co-enrollment

Contamination?

  

Data interpretation

  13. Power to determine interactions

Sufficient/insufficient?

  

  14. Attribution of adverse events

Easy/difficult?

  

Feasibility/burden

  15. Parent/legal guardian burden

Yes/no?

  

  16. Site investigator burden

Yes/no?

  

  17. Bedside clinical team burden

Yes/no?

  

  18. Current sharing scheme

Yes/no?

  

Additional considerations

  19. Impact on publication

Known/unknown?

  

  20. Intervention use off-protocol

Yes/no?

  

  21. Priority

High/low?

  

  22. Possible sharing arrangement

Â